Vascular endothelial growth factor inhibitors(Bayer Healthcare)
血管内皮生长因子抑制剂（拜耳医药）
Report date: 2022/01/14 13:23:58
Base Information
Drug NameVascular endothelial growth factor inhibitors(Bayer Healthcare)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[4]
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaPending
Originator CompaniesBayer Healthcare Company LtdRegeneron Pharmaceuticals Inc
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A